Skip to main content
SpringerLink
Log in

The spectrum of urological disease in patients with spina bifida

  • Original Paper
  • Published:
Irish Journal of Medical Science Aims and scope Submit manuscript

Abstract

Backround Urological complications are the major cause of ill health during childhood and adult life of patients with spina bifida but the significance of urinary tract disease on the individual and the healthcare services is underemphasised.

Aim To assess the effects of spina bifida on the individual and the healthcare services.

Methods A retrospective review was performed to assess the frequency and significance of urological conditions requiring hospital attendance in patients with spina bifida currently attending a specialised multidisciplinary clinic over a period of six months.

Results Urinary sepsis accounted for the majority of admissions (62%), while 38 of 62 patients required 60 surgical procedures. Targeting the primary urological abnormality (the dysfunctional and usually poorly compliant bladder) allows implementation of effective treatments, including regular intermittent bladder catherisation (52%) in order to preserve upper renal tract function. Associated postural abnormalities complicated both conservative and interventional therapies.

Conclusion This study highlights the surgical commitment for units caring for patients with spina bifida, the important considerations for the future healthcare services, and the range and severity of urological diseases encountered by these patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. McDonnell GV, McCann JP. Why do adults with spina bifida and hydrocephalus die?Eur J Pediatr Surg 2000; 10 (suppl 1): 31–2.

    PubMed  Google Scholar 

  2. Singhal B, Mathew KM. Factors affecting mortality and morbidity in adult spina bifida patients.Eur J Pediatr Surg 1999; 9 (suppl 1): 31–2.

    PubMed  Google Scholar 

  3. Brown S, Marshall D, Patterson D et al. Chronic pyelonephritis in association with n€pathic bladder.Eur J Pediatr Surg 1999; 9 (suppl 1): 29–30.

    PubMed  Google Scholar 

  4. McDonnell GV, McCann JP. Issues of medical management in adults with spina bifida.Childs Nerv Syst 2000; 16 (4): 222–7.

    Article  PubMed  CAS  Google Scholar 

  5. Elwood JM, Elwood JH. Epidemiology of anacephalus and spina bifida. Oxford University Press, 1980.

  6. McLone DG. Spina bifida today: problems adults face.Semin N€l 1989; 9: 169–75.

    CAS  Google Scholar 

  7. Graf RA, Smith JH, Flock RH et al. Urinary tract changes associated with spina bifida and myelomeningocele.Amer J Roentgen 1964; 92: 255–9.

    PubMed  CAS  Google Scholar 

  8. McDonnell RJ, Johnson Z, Delaney V et al. East Ireland 1980- 1994: Epidemiology of neural tube defects.J Epidemiol Community Health 1999; 53 (12): 782–88.

    PubMed  CAS  Google Scholar 

  9. Sarwark JF. Spina bifida.Paediatric Clin North Am. 1996; 43 (5): 1151–8.

    Article  CAS  Google Scholar 

  10. Murphy M, Whiteman D, Stone D et al. Dietary folate and the prevalence of neural tube defects in the British Isles: the past two decades.BJOG 2000; 107 (7): 885–9.

    Article  PubMed  CAS  Google Scholar 

  11. O’Leary M, O’Donnell RM, Johnson H. Folic acid and prevention of neural tube defects in 2000: improved awareness- low periconceptual uptake.Ir Med J 2001; 94 (6): 180–1.

    CAS  Google Scholar 

  12. Byrne J, Byrne C, Collins D. Trends in periconceptual folic acid use by relatives in Irish families with neural tube defects.Ir Med J 2001; 94 (10): 302–5.

    PubMed  CAS  Google Scholar 

  13. Kiely EA. The €pean Board of Urology survey of current urological manpower, training and practice in €pe.BJU International 2000; 85: 8–13.

    Article  PubMed  CAS  Google Scholar 

  14. The Senate of Surgery of Great Britain and Ireland. The provision of general surgical services for children. Senate Paper No.3, July 1998.

  15. Arul GS, Spicer RD. Where should paediatric surgery be performed?Arch Dis Child 1998; 79: 65–72.

    PubMed  CAS  Google Scholar 

  16. Johnston LB, Borzyskowski M. Bladder dysfunction and n€logical disability at presentation in closed spina bifida.Arch Dis Child 1998; 79: 33–8.

    Article  PubMed  CAS  Google Scholar 

  17. Bauer SB, Hallett M, Khosbin S et al. Predictive value of urodynamic evaluations in newborns with myelomeningocele.JAMA 1984; 252: 650–2.

    Article  PubMed  CAS  Google Scholar 

  18. Kobayashi S, Shinno Y, Kakizaki H et al. Relevance of detrusor hyperreflexia, vesical compliance and urethral pressure to the occurrence of vesicoureteral reflux in myelodyxplastic patients.J Urol 1992; 147 (2): 413–5.

    PubMed  CAS  Google Scholar 

  19. Lane TM, Shah PJR. Leak-point pressures.BJU Int 2000; 86: 942–49.

    Article  PubMed  CAS  Google Scholar 

  20. Steinhart GF, Goodgold HM, Samuels LD. The effect of intravesical pressure on glomerular filtration rate in patients with myelomeningocele.J Urol 1988; 140 (2): 1293–5.

    Google Scholar 

  21. McLorie GA, Perez-Maero R, Csima A et al. Determinants of hydronephrosis and renal injury in patients with myelomeningocele.J Urol 1988; 140: 1289–92.

    PubMed  CAS  Google Scholar 

  22. McGuire EJ, Woodside JR, Borde TA. Upper urinary tract deterioration in patients with myelomeningocele and detrusor hypertonia.J Urol 1983; 129: 823.

    PubMed  CAS  Google Scholar 

  23. Uehling DT, Smith J, Meyer J et al. Impact of clean intermittent catherisation on children with myelomeningocele.Paediatrics 1985; 76: 892–5.

    CAS  Google Scholar 

  24. Fernandes ET, Reinberg Y, Vernier R et al. N€genic bladder dysfunction in children: Review of pathophysiology and current management.J Paediatrics 1994; 124 (1): 1–7.

    Article  CAS  Google Scholar 

  25. Skobejko-Wlodarska L, Strulak K, Nachulewicz P et al. Bladder autoaugmentation in myelodysplastic children.BJU Int 1998; 81 (s 4).

  26. Wyndaele JJ, Maes D. Clean intermittent self-catherisation: a 12- year follow up.J Urol 1990; 143: 906–8.

    PubMed  CAS  Google Scholar 

  27. Lindehall B, Moller A, Hjalmas K et al. Long-term intermittent catherisation: The experience of teenagers and young adults with myelomeningocele.J Urol 1994; 152: 187–9.

    PubMed  CAS  Google Scholar 

  28. Kaefer M, Pabby A, Kelly M et al. Improved bladder function after prophylactic treatment of the high-risk n€genic bladder in newborns with myelomeningocele.J Urol 1999; 162 (3 Pt 2): 1068–71.

    Article  PubMed  CAS  Google Scholar 

  29. Fichtner J. Follow-up after urinary diversion.Urol Int 1999; 63 (1): 40–5.

    Article  PubMed  Google Scholar 

  30. Wein AJ. Pharmacologic options for the overactive bladder.Urology 1998; 51 (Suppl 2A): 43–7.

    Article  PubMed  CAS  Google Scholar 

  31. Park JM, Schwartz AC, Garwood CK et al. External sphincter dilatation in the management of high-risk patients with myelomeningocele: a 15 year experience.BJU Int 2000; 85 (s4).

  32. Tanaka H, Kakizaki H, Kobayashi S et al. The relevance of urethral resistance in children with myelodysplasia: its impact on upper urinary tract deterioration and the outcome of conservative management.J Urol 1999; 161 (3): 929–32.

    Article  PubMed  CAS  Google Scholar 

  33. Lose G, Norgaard JP. Intravesical oxybutynin for incontinence resulting from an overactive detrusor.BJU Int 2001; 87: 767–73.

    Article  PubMed  CAS  Google Scholar 

  34. Ferrara P, D’Aleo CM, Tarquini E et al. Side-effects of oral or intravesical oxybutynin chloride in children with spina bifida.BJU Int 2001; 87: 674–8.

    Article  PubMed  CAS  Google Scholar 

  35. Zawin JK, Lebowita RL. N€genic dysfunction of the bladder: Recent advances and the role of radiology.Radiology 1992; 182: 297–304.

    PubMed  CAS  Google Scholar 

  36. Mevorach RA, Bogaert GA, Baskin LS et al. Lower urinary tract function in ambulatory children with spina bifida.Br J Urol 1996; 77: 593–6.

    PubMed  CAS  Google Scholar 

  37. Seki N, Akazawa K, Senoh et al. An analysis of risk factors for upper urinary tract deterioration in patients with myelodysplasia.BJU Int 1999; 84 (6): 679–82.

    Article  PubMed  CAS  Google Scholar 

  38. Persun ML, Ginsberg PC, Harmon JD et al. Role of urologic evaluation in the adult spina bifida patient.Urol Int 1999; 62 (4): 205–8.

    Article  PubMed  CAS  Google Scholar 

  39. Hopps CV, Kropp KA. Preservation of renal function in children with myelomeningocele managed with basic newborn evaluation and close follow-up.J Urol 2003; 169 (1): 305–8.

    Article  PubMed  Google Scholar 

  40. Chan YL, Chan KW, Yeung CK et al. Potential utility of MRI in the evaluation of children at risk of renal scarring.Pediatr Radiol 1999; 29 (11): 856–62.

    Article  PubMed  CAS  Google Scholar 

  41. Shipstone DP, Thomas DG, Darwent G et al.BJU Int 2002; 89 (7): 658–64.

    Article  PubMed  CAS  Google Scholar 

  42. Maher MM, Tripuraneni PAS, Fitzpatrick JM et al. Spinal dysraphism at MR Urography: Initial experience.Radiology 2000; 216: 237–41.

    PubMed  CAS  Google Scholar 

  43. Culp DA, Bekard A, Flocks RH. Urological management of the myelomeningocele patient.JAMA 1970; 213 (5): 753–8.

    Article  PubMed  CAS  Google Scholar 

  44. Wiswell TE, Tuttle DJ, Northam RS et al. Major congenital n€logic malformations. A 17 year review.Am J Dis Child 1990; 144 (1): 61–7.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Cork University Hospital, Ireland

    RA Cahill & EA Kiely

Authors
  1. RA Cahill
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. EA Kiely
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to RA Cahill.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cahill, R., Kiely, E. The spectrum of urological disease in patients with spina bifida. Ir J Med Sci 172, 180–184 (2003). https://doi.org/10.1007/BF02915286

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02915286

Keywords

Search

Navigation